कृपया अन्य खोज का प्रयास करें
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company’s lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans, as well as with the Montreal Heart Institute, the WCN network, and other research centers. The company was incorporated in 2003 and is headquartered in Montréal, Canada.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Philippe Douville | 61 | 2005 | Founder, Strategic Advisor & Member of Scientific Advisory Board |
Harry A. Kopelman | - | - | Member of the Scientific Advisory Board |
John DiMarco | - | - | Member of the Scientific Advisory Board |
Harry Jefferson Leighton | 77 | - | Member of the Scientific Advisory Board |
Debra K. Liebert | 67 | 2015 | Independent Non-Executive Director |
Albert L. Waldo | - | - | Member of the Scientific Advisory Board |
Michael John Tomsicek | 57 | 2019 | Independent Non-Executive Director |
Daniel R. Omstead | 70 | 2017 | Observer |
Joseph G. Oliveto | 55 | 2017 | CEO, President & Director |
Jean-Yves Le Heuzey | - | - | Member of the Scientific Advisory Board |
John Camm | - | - | Member of the Scientific Advisory Board |
Paul Dorian | - | - | Member of the Scientific Advisory Board |
Richard C. Pasternak | 74 | 2019 | Independent Non-Executive Director |
Seth H. Z. Fischer | 67 | 2023 | Independent Non-Executive Director |
Peter R. Kowey | - | - | Member of the Scientific Advisory Board |
Lisa M. Giles | 64 | 2020 | Independent Non-Executive Director |
Robert James Wills | 69 | 2020 | Independent Chairman of the Board |
Philip T. Sager | 68 | 2020 | Chief Medical Advisor & Member of the Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है